Literature DB >> 22953502

Diagnostic role of rapid on-site cytologic examination (ROSE) of broncho-alveolar lavage in ALI/ARDS.

C Ravaglia1, C Gurioli, G Casoni, M Romagnoli, S Tomassetti, C Gurioli, R M Corso, G Poletti, A Dubini, A Marinou, V Poletti.   

Abstract

BACKGROUND: While bronchoscopy should be considered in patients with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in which the cause cannot be determined from history or clinical and laboratory data, there are no studies about the utility of rapid on-site examination (ROSE) of broncho-alveolar lavage for identification, as early as possible, of the pathological condition underlying the onset of this condition. The aim of this prospective, observational study was to evaluate the diagnostic role of ROSE of BAL in ALI/ARDS.
METHODS: 71 patients with ALI/ARDS underwent bronchoalveolar lavage, and one part of the sample was examined with ROSE. The on-site report was categorized as diagnostic (specific diagnosis), presence of atypical reactive type II pneumocytes with no further comments or not diagnostic.
RESULTS: ROSE of bronco-alveolar lavage yielded 29 (41%) specific diagnoses, revealed typical features of diffuse alveolar damage without a specific diagnosis in 28 patients (39%) and did not reveal a specific diagnosis in the remaining 14 cases (20%).
CONCLUSIONS: The results of this study show that, in patients with ALI/ARDS, bronchoalveolar lavage with ROSE is diagnostic in 40% of cases: ROSE may therefore spare lung biopsies and improve the prognosis of patients with ARDS (immunocompetent or not) as therapy could be started or modified at a very early phase.

Entities:  

Mesh:

Year:  2012        PMID: 22953502

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  2 in total

1.  Influenza A/H1N1 Severe Pneumonia: Novel Morphocytological Findings in Bronchoalveolar Lavage.

Authors:  Paola Faverio; Stefano Aliberti; Clinton Ezekiel; Grazia Messinesi; Ambrogio Brenna; Alberto Pesci
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-10-14

Review 2.  Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.

Authors:  Antonio Cuneo; Giovanni Barosi; Romano Danesi; Stefano Fagiuoli; Paolo Ghia; Alfredo Marzano; Marco Montillo; Venerino Poletti; Pierluigi Viale; Pier Luigi Zinzani
Journal:  Hematol Oncol       Date:  2018-09-05       Impact factor: 5.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.